Find uplifting stories about heroes, innovations, and solutions
7378 results for "immunotherapy advances"
A young woman with advanced colorectal cancer is now cancer-free after receiving a groundbreaking dual immunotherapy treatment that took just four months. She even ran a 5K during treatment, avoiding the debilitating side effects of traditional chemotherapy.
Saudi Arabia just became the first country in the world to approve Anktiva, a groundbreaking immunotherapy for advanced lung cancer patients who've run out of options. The treatment gives new hope to patients whose disease has progressed despite standard therapies.
Patients with advanced anal cancer finally have a treatment option approved in the European Union after decades without meaningful progress. The new drug combination shows real promise for extending lives in a rare but serious disease.
Scientists discovered how cancer cells hide from cutting-edge immunotherapy and used an existing drug to make the treatment work again. Six patients whose immune cell therapy had stopped working saw their cancer respond once more.
Scientists at UCLA have achieved breakthrough results in treating advanced colorectal cancer, with a new combination therapy doubling two-year survival rates. The research team is also making major strides in prevention, from mailing free screening kits to developing powerful cancer vaccines.
A $50,000 grant is helping Canadian researchers unlock why the deadliest brain cancer resists treatment that works for other cancers. The early-stage work could lead to the first effective immunotherapy for glioblastoma patients.
After nearly a century of research, immunotherapy treatments are curing some cancers without surgery, chemotherapy, or radiation. Patients like 71-year-old Maureen Sideris are seeing tumors disappear after just months of treatment.
The Cancer Research Institute launched a patient resource hub connecting cancer patients with immunotherapy information and clinical trials. The platform features survivor stories and treatment guidance for those exploring cutting-edge cancer care options.
After 12 years and multiple melanoma diagnoses, Joe Eastin faced his toughest challenge when the cancer spread to his bones. Cutting-edge immunotherapy shrank his tumor by 50% in just three months.
New targeted therapies and immunotherapies for lung cancer are now reaching over 60% of patients with advanced disease, a dramatic improvement in treatment access. Fifteen states have enacted laws requiring insurance coverage for biomarker testing that helps match patients to lifesaving treatments.
After four months of immunotherapy infusions, a 71-year-old woman's esophageal cancer vanished completely without surgery, chemotherapy, or radiation. Scientists say these breakthrough treatments are finally hitting their stride after nearly 100 years of development.
Japanese researchers discovered that widely prescribed statin drugs could help cancer immunotherapy work better by blocking tumors' ability to suppress the immune system. The breakthrough offers hope for millions since statins are already safe, affordable, and available worldwide.
A groundbreaking treatment just became available to thousands of European women whose ovarian cancer stopped responding to standard chemotherapy. The approval marks the first time an immunotherapy has been authorized in the EU for this hard-to-treat condition.
Scientists discovered how lung tumors hijack the body's immune safety system to protect themselves from treatment. The breakthrough could help immunotherapy work for thousands more cancer patients.
A new immunotherapy drug for aggressive stomach cancer just got the green light from the NHS, marking the first major treatment breakthrough in nearly ten years. About 1,500 people a year in the UK will now have access to a therapy that extends survival and reduces cancer recurrence.
A silver Lab named Clarice beat cancer using an experimental treatment that's now paving the way for new immunotherapy options for children. The trial combined surgery, radiation, and immune-boosting injections to save her leg and her life.
Pope John XXIII Regional High School in Sparta celebrated a remarkable achievement as 67 students earned Advanced Placement scholar honors for their outstanding performance on 2020 AP exams. The Catholic school's success shows how dedicated students and teachers can achieve academic excellence together.
Around 1,500 people with stomach cancer will gain access to a groundbreaking immunotherapy treatment that extends survival and reduces recurrence. It's the first major advance in stomach cancer care in nearly ten years.
Researchers accidentally discovered a protein that appears only on cancer cells, not healthy tissue. This breakthrough could help doctors create more precise cancer treatments with fewer side effects.
A groundbreaking immunotherapy drug halted or shrank tumors in nearly half of men with advanced prostate cancer who had run out of treatment options. The therapy works differently than previous treatments and caused only mild side effects in 88% of patients.
Showing 20 of 7378